IHE icon

iShares US Pharmaceuticals ETF
IHE

Overview Fund Activity

102 hedge funds and large institutions have $311M invested in iShares US Pharmaceuticals ETF in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 4 closing their positions.

Holders
102
Holders Change
+16
Holders Change %
+18.6%
% of All Funds
2.72%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
21
Increased
31
Reduced
30
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
BCM
1
Brookstone Capital Management
Illinois
$15.6M
2
BWM
2
Braver Wealth Management
Massachusetts
$12.4M
3
Citadel Advisors
3
Citadel Advisors
Florida
$4.35M
4
Wells Fargo
4
Wells Fargo
California
$23.6M
5
SG Americas Securities
5
SG Americas Securities
New York
$2.93M

Top Sellers

1
Bank of Montreal
1
Bank of Montreal
Ontario, Canada
$883K
2
RJA
2
Raymond James & Associates
Florida
$5.28M
3
TRCT
3
Tower Research Capital (TRC)
New York
$1.1M
4
Bank of America
4
Bank of America
North Carolina
$41.6M
5
Morgan Stanley
5
Morgan Stanley
New York
$41.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
TFA
101
Transamerica Financial Advisors
Florida
$1K – – –
BRWA
102
B. Riley Wealth Advisors
Florida
$183 +$183 +3,633 New
VKH
103
Virtu KCG Holdings
New York
– -$493K -10,533 Closed
MHS
104
M Holdings Securities
Oregon
– -$171K -3,654 Closed
SCA
105
Strategic Capital Alternatives
United States
– -$52K -1,113 Closed
Fifth Third Bancorp
106
Fifth Third Bancorp
Ohio
– -$11K -225 Closed
1 2 3 4
5